532 related articles for article (PubMed ID: 10640953)
41. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
[TBL] [Abstract][Full Text] [Related]
42. Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis.
Ue T; Yokozaki H; Kagai K; Higashikawa K; Yasui W; Sugiyama M; Tahara E; Ishikawa T
J Oral Pathol Med; 1998 May; 27(5):197-201. PubMed ID: 9682981
[TBL] [Abstract][Full Text] [Related]
43. Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression.
Zhang X; Han S; Han HY; Ryu MH; Kim KY; Choi EJ; Cha IH; Kim J
Pathology; 2013 Aug; 45(5):478-83. PubMed ID: 23811806
[TBL] [Abstract][Full Text] [Related]
44. DNA ploidy analysis by image cytometry helps to identify oral epithelial dysplasias with a high risk of malignant progression.
Torres-Rendon A; Stewart R; Craig GT; Wells M; Speight PM
Oral Oncol; 2009 Jun; 45(6):468-73. PubMed ID: 18805043
[TBL] [Abstract][Full Text] [Related]
45. Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma.
Iamaroon A; Khemaleelakul U; Pongsiriwet S; Pintong J
J Oral Pathol Med; 2004 Jan; 33(1):30-6. PubMed ID: 14675138
[TBL] [Abstract][Full Text] [Related]
46. Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells.
Dai J; Wei W
Arch Oral Biol; 2017 Nov; 83():40-46. PubMed ID: 28697409
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of the Ca 1 monoclonal antibody in distinguishing oral squamous cell carcinoma from non-malignant or premalignant oral lesions.
Masouredis CM; Green TL; Greenspan JS
J Oral Pathol; 1987 Jul; 16(6):307-9. PubMed ID: 3119804
[TBL] [Abstract][Full Text] [Related]
48. Expression of the CA1 determinant by carcinomas and by non-malignant epithelial cells in oral lesions.
Shabana AH; Ivanyi L; Kramer IR
Br J Cancer; 1983 Oct; 48(4):527-31. PubMed ID: 6354238
[TBL] [Abstract][Full Text] [Related]
49. [Immunohistochemical study of benign lymphoadenosis of oral mucosa].
Li SX; Yu SF; Sun KH
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Sep; 39(5):410-3. PubMed ID: 15498351
[TBL] [Abstract][Full Text] [Related]
50. [Expression of voltage-gated potassium channel Kv3.4 in oral squamous cell carcinoma].
Wang R; Cai B; Xiang J; Zhu X; Jiang Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2016 Mar; 51(3):137-42. PubMed ID: 26980650
[TBL] [Abstract][Full Text] [Related]
51. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
[TBL] [Abstract][Full Text] [Related]
52. Correlation between immunohistochemical staining of CEACAM1 and clinicopathological findings in oral pre-neoplastic lesions and squamous cell carcinoma.
Simonetti O; Lucarini G; Rubini C; Zizzi A; Aspriello SD; Di Primio R; Offidani AM
Med Mol Morphol; 2018 Mar; 51(1):41-47. PubMed ID: 28887602
[TBL] [Abstract][Full Text] [Related]
53. Apoptosis in premalignant and malignant squamous cell lesions of the oral cavity: a light microscopic study.
Jain A; Maheshwari V; Alam K; Mehdi G; Sharma SC
Indian J Pathol Microbiol; 2009; 52(2):164-6. PubMed ID: 19332902
[TBL] [Abstract][Full Text] [Related]
54. Overexpression of p53 protein in squamous cell carcinoma of buccal mucosa and tongue in Taiwan: an immunohistochemical and clinicopathological study.
Yan JJ; Tzeng CC; Jin YT
J Oral Pathol Med; 1996 Feb; 25(2):55-9. PubMed ID: 8667256
[TBL] [Abstract][Full Text] [Related]
55. Cytoplasmic expression of SOX9 as a poor prognostic factor for oral squamous cell carcinoma.
Sumita Y; Yamazaki M; Maruyama S; Abé T; Cheng J; Takagi R; Tanuma JI
Oncol Rep; 2018 Nov; 40(5):2487-2496. PubMed ID: 30132562
[TBL] [Abstract][Full Text] [Related]
56. [Centrosome hyperamplificationin oral precancerous lesions and squamous cell carcinomas].
Cai Y; Li BQ; Cheng QM
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Jun; 22(3):238-41. PubMed ID: 15293475
[TBL] [Abstract][Full Text] [Related]
57. An immunohistochemical study of thrombomodulin in oral squamous cell carcinoma and its association with invasive and metastatic potential.
Tabata M; Sugihara K; Yonezawa S; Yamashita S; Maruyama I
J Oral Pathol Med; 1997 Jul; 26(6):258-64. PubMed ID: 9234185
[TBL] [Abstract][Full Text] [Related]
58. Comparative genomic hybridization reveals genetic progression of oral squamous cell carcinoma from dysplasia via two different tumourigenic pathways.
Noutomi Y; Oga A; Uchida K; Okafuji M; Ita M; Kawauchi S; Furuya T; Ueyama Y; Sasaki K
J Pathol; 2006 Sep; 210(1):67-74. PubMed ID: 16767698
[TBL] [Abstract][Full Text] [Related]
59. Use of carcinogen-induced premalignant oral lesions in a dendritic cell-based vaccine to stimulate immune reactivity against both premalignant oral lesions and oral cancer.
Young MR
J Immunother; 2008; 31(2):148-56. PubMed ID: 18481384
[TBL] [Abstract][Full Text] [Related]
60. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
Chhieng DC; Benson E; Eltoum I; Eloubeidi MA; Jhala N; Jhala D; Siegal GP; Grizzle WE; Manne U
Cancer; 2003 Dec; 99(6):365-71. PubMed ID: 14681945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
